Bioventix Share Discussion Threads

[gsbmba99] 26/4/2019 15:25

Uni article on new research published here - - with an encouraging quote: "People over 40 already have ‘health MOTs’ which examine their blood pressure, cholesterol levels and the like. Adding a troponin test could prove to be a valuable early-warning system to identify the specific types of heart problem they might face in the future and take steps to address them early on."

[stepone68] 26/4/2019 13:03

Wow! Dividend has arrived on the right day, in both my accounts. This is a first. Took ten days last year!

[gsbmba99] 16/4/2019 19:35

The transition is complex not least because they changed unit of measurement. Pres from Duke Univ in US. pp 18-20 - timescale and breadth of departments involved. p 11 shows PPV/NPV by the value of the reading. The limit of detection for most assays is about 2 so measurable in most healthy indivs. Most tests will be trop "positive" but not "abnormal" and requires huge shift in mindset.

[apad] 16/4/2019 18:07

That's how I see it, gsb...
We'll be a little impatient for results, but these things move conservatively.
Ta.
apad

[gsbmba99] 16/4/2019 16:58

Given the stickiness of the customer base, it's probably useful to have the big 5 all banging the drum for hs-troponin in Europe. Also, it helps give the impression the pace of switching has increased when customers of all 5 exchange experiences about converting at the next industry conference. More conversions with more experience and more documentation should ease the process for the rest.

[gsbmba99] 16/4/2019 16:54

The machines for eg Siemens are like a captive installed base because the machines and the reagents are sold on a razor/razor blade model with renewable multi-year contracts. The machines run upwards of 100 tests so if you're happy with the other 99 do you switch for 1? Roche had the US market to themselves for 18 months on troponin and I doubt anybody threw out their Siemens machine for a Roche just for troponin.

[apad] 16/4/2019 16:35

gsb
As I understand it the cost of machines is the determinant.
So, if your hospital has Siemens machines you will use their cardiac troponin.
The machines are used for lots of stuff so you won't change your machine for one chemical test that might be better/worse/different from another.
So the BVXP troponin will roll out into the Siemens machine space at whatever the pace of acceptance is.
Am I correct(ish)?
apad

[gsbmba99] 16/4/2019 16:24

Ortho Clinical announced CE marking for their hs-troponin test today. Each of the big 5 (Roche, Siemens, Beckman, Abbott and Ortho) now have a CE marked hs-troponin test. Abbott and Ortho not yet approved in US.

[diviincomesearch] 12/4/2019 12:18

Managed to get a bid at £39.05 for a few shares today- will hold onto the rest.

[igbertsponk] 11/4/2019 14:43

Perhaps undelayed

[stepone68] 11/4/2019 09:45

Delayed reaction?

[igbertsponk] 11/4/2019 09:40

You spoke too soon!

[stepone68] 11/4/2019 09:27

Always a big spread here, so it's hard to tell, but the 30p ex divi appears to have made little difference to the price - if anything it's gone up.

[lauders] 11/4/2019 02:36

Buyers entering/topping up last session for ex-dividend today it would seem. Will be interesting to see how much of a drop occurs by the end of today's session.

Listed here as ex-dividend today:

[igbertsponk] 03/4/2019 14:49

Clickable link. You need to put a Capital in it to make the link work.

[johnsmith321] 03/4/2019 12:04

Here is a nice overview of the high sensitivity troponin study that IgbertSponk
linked to. See the comments from researchers not linked to the study in p3 particularly.

[red5] 03/4/2019 11:29

Buying oportunity

[wjccghcc] 29/3/2019 10:40

Oops sorry, read it too fast. Yes, 100k.

[steptoes yard] 29/3/2019 10:21

Ah 100k, ok, thanks.

[gsbmba99] 29/3/2019 10:07

"We are reducing revenues for FY 2019 from £0.36m to £0.10m and for FY 2020 from c.£0.9m to £0.6m." From today's finnCap note p. 6. Note it's not 10k but £100k. No changes to overall forecasts as troponin reductions picked up by other parts of portfolio. You can register for free access to finnCap research.

[steptoes yard] 29/3/2019 10:00

WJ, Where did you see that forecast please? Not saying it isn't there, I just cannot see it?

[wjccghcc] 29/3/2019 07:46

Troponin forecast reduced again from 360k to 10k. However, Vit D is compensating for it.

[igbertsponk] 29/3/2019 07:44

Yes. Usual cautionary narrative but the figures are good and a nice dividend increase

[valustar1] 29/3/2019 07:11

Results out and look good